SEEearlySupported Employment and Education for Early Psychosis Recovery
Individual Placement and Support (IPS)
Mental Disorders+1
+ Psychotic Disorders
+ Schizophrenia
Treatment Study
Summary
Study start date: October 18, 2022
Actual date on which the first participant was enrolled.Psychotic disorders often develop a chronic course with devastating consequences for individuals, families, and societies usually with first onset during adolescence and early adulthood. Early intervention programs, which provide intensive, phase specific, psychosocial, and pharmacological treatment for people in the first five years after the initial psychotic episode (early psychosis) can significantly improve the outcome and are therefore strongly recommended in national and international guidelines. However, most early intervention programs in people with early psychosis still focus on improving symptoms and relapse prevention, rather than targeting educational and vocational recovery, although engagement in work and education is a high priority for young people with early psychosis and reduces the social disability associated with the disorder. The aim of the present study is to explore the effects of Supported Employment and Education (SEE) following the Individual Placement and Support (IPS) model in people with early psychosis. The investigators compare treatment as usual (TAU) in an outpatient psychiatric setting to TAU plus SEE.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.184 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 16 to 35 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 6 locations
Klinik für Sozialpsychiatrie, Zentrum für Psychiatrie Reichenau
Reichenau, GermanyOpen Klinik für Sozialpsychiatrie, Zentrum für Psychiatrie Reichenau in Google MapsKlinik für Psychiatrie und Psychotherapie, LMU Klinikum
München, GermanyKlinik für Psychiatrie, Psychotherapie und Psychosomatik II, Günzburg
Ulm, GermanyKlinik für Psychiatrie und Psychotherapie Charité Campus Mitte
Berlin, Germany